Abstract
Get full access to this article
View all access options for this article.
References
1.
Hollingworth
P
,
Harold
D
,
Sims
R
,
Gerrish
A
,
Lambert
JC
,
Carrasquillo
MM
,
Abraham
R
,
Hamshere
ML
,
Pahwa
JS
,
Moskvina
V
,
Dowzell
K
et al. 2011 . Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease . Nat Genet , 43 :429 -435 .
2.
Naj
AC
,
Jun
G
,
Beecham
GW
,
Wang
LS
,
Vardarajan
BN
,
Buros
J
,
Gallins
PJ
,
Buxbaum
JD
,
Jarvik
GP
,
Crane
PK
et al. 2011 . Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease . Nat Genet , 43 :436 -441 .
3.Spinal Muscular Atrophy Foundation . 2010 . SMA Foundation announces completion of the biomarker discovery study: over 400 candidate biomarkers identified . www.smafoundation.org/news-92-sma-foundation-announces-the-discovery-of-over-400-candidate-biomarkers-from-the-bforsma-study.html. 2011 June 29 .
4.
Suthram
S
,
Dudley
JT
,
Chiang
AP
,
Chen
R
,
Hastie
TJ
,
Butte
AJ
2010 . Network-based elucidation of human disease similarities reveals common functional modules enriched for pluripotent drug targets . PLoS Comput Biol , 6 :e1000662 .
5.
Terry
SF
. 2010 . Accelerate medical breakthroughs by ending disease earmarks . Nat Rev Genet , 11 :310 .
6.
Tiziano
FD
,
Neri
G
,
Brahe
C
2010 . Biomarkers in rare disorders: the experience with spinal muscular atrophy . Int J Mol Sci , 12 :24 -38 .